Every year, an estimated 1.5 million patients are subjected to the diagnostic tests of Mycobacterium tuberculosis in Ind...
New Delhi: Venus Remedies received Good Manufacturing Practices (GMP) approval from the Therapeutic Goods Administratio...
Mumbai: Lupin's subsidiary Lupin Pharmaceuticals, US, launched its Fenofibrate tablets (48 mg and 145 mg strengths) in ...
Singapore: Telezon has dispatched the first of three shiments for the 500,000 SoloFlow commercial order to Serum Institu...
Singapore: As a measure, to improvise on Indian exports, the US Food and Drug Administration (USFDA) has deputed three s...
Singapore: Aeras, a not-for-profit fully integrated tuberculosis vaccine development organization, has signed an agreeme...
Bangalore: Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories, has entered into an in-licensing...
Immunotherapy is a very active area of cancer research wherein the treatment makes the immune system fight against cance...
It is estimated that about 40-to-60 percent of the Indian population still doesn't have access to vital life saving drug...
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmac...
Mumbai: Opto Circuits, India, appointed Mr Krishna Sudheendra as the group chief financial officer. This was approved by...
Singapore: Mylan reported its financial results for the three and six months ending on June 30, 2012. The company's adju...
Hyderabad: BioAsia, Asia's biggest technology and bio-business platform, today kick started with an inauguration ceremo...
Singapore: Drug major Wockhardt has decided to recall over 8,000 bottles of anti-hypertension drug Metoprolol Succinate ...
Bangalore: The US FDA granted final approval to India-based Aurobindo Pharma to manufacture and market rizatriptan benzo...
Bangalore: Pharma majors Lupin and Aurobindo have announced that they have received approvals for their respective gener...
Bangalore: Open-access peer-reviewed medical journal BMJ, which was originally called the British Medical Journal until ...
New Delhi: The Indian government will be reviewing the foreign direct investment (FDI) policies for the pharmaceutical i...
